NT5E and clear cell adenocarcinoma: In that study, 29.9% of the patients had CD73− tumors, and the rest had a variable level of CD73 expression, with CD73 being more frequently expressed in mucinous and in clear cell carcinoma, compared to serous and endometriod adenocarcinoma [59].